News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Concert Pharmaceuticals, Inc. (CNCE) Announces Filing Of Its Annual Report On Form 10-K



3/31/2014 8:02:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) announced today that it has filed its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission.

A copy of the Annual Report on Form 10-K is available to be viewed or downloaded from the Investors & Media section of Concert's website at www.concertpharma.com. Concert stockholders or other interested parties may obtain a hard copy of the Annual Report on Form 10-K, free of charge, by contacting Concert’s Investor Relations Department at: 99 Hayden Avenue, Suite 500, Lexington, MA 02421, or by email at: ir@concertpharma.com.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES